1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AUROBINDO PHARMA LTD.

Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804

Mid-range Performer

1220.10 -37.70 (-3.00%)

52W Low on Apr 07, 2025

803.9K NSE+BSE Volume

NSE 25 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
US FDA Approval
Aurobindo Pharma gets US FDA approval for Dasatinib Tablets with a market size of $1.8 bn See details

Detailed Stock Analysis for Aurobindo Pharma Ltd. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe Sign in